The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)

Clinical trial NCT00872001 · TERMINATED

Trial details

NCT number: NCT00872001
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Coronary Artery Bypass Myocardial Infarction Ventricular Dysfunction, Left Stroke Cardiopulmonary Bypass

Start date: 2009-04-01
Primary completion: 2010-10-01
Enrollment: 3080

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.